For the Inventor, By the Inventor

Enter assignee name

Tel Aviv, Israel

Azura Ophthalmics Ltd.

USPTO Granted Patents = 21

EPO Patents = 2

Forward Citations = 94

Loading Chart...

Loading Chart...

20 inventors (with patents filed for the assignee):

Omer Rafaeli (20 out of 36 patents)

Yair Alster (13 out of 85 patents)

Shimon Amselem (13 out of 38 patents)

4. Doron Friedman (12 out of 72 patents)

5. Charles Bosworth (8 out of 9 patents)

6. Yair Alster (8 out of 15 patents)

7. Cary J Reich (7 out of 129 patents)

8. Marc Gleeson (6 out of 6 patents)

9. Hila Epstein-Barash (5 out of 5 patents)

10. Kirsten Angela Macfarlane (5 out of 5 patents)

11. Ian Holmes (4 out of 4 patents)

12. Hila Barash (4 out of 4 patents)

13. Mark Richard Stewart (4 out of 9 patents)

14. Jonathan Dunn (4 out of 4 patents)

15. Zakhar Nudelman (3 out of 4 patents)

21 patents: Sort by Forward Citations

1. 12697352 - Instructions for composition and sensitivity (2026-08-04),

2. 12527817 - Manufacturing of selenium disulfide compositions (2026-01-20),

3. 12458661 - Selenium disulfide compositions for use in treating meibomian gland dysfunction (2025-11-04),

4. 12447162 - Compositions and methods for the treatment of meibomian gland dysfunction (2025-10-21),

5. 12427158 - Compositions and methods for the treatment of meibomian gland dysfunction (2025-09-30),

6. 12083147 - Compositions and methods for the treatment of contact lens discomfort (2024-09-10),

7. 12048707 - Compositions and methods for the treatment of meibomian gland dysfunction (2024-07-30),

8. 12011457 - Selenium disulfide compositions for use in treating meibomian gland dysfunction (2024-06-18),

9. 11643429 - Compounds and methods for the treatment of ocular disorders (2023-05-09),

10. 11634411 - Compounds and methods for the treatment of ocular disorders (2023-04-25),

11. 11633410 - Compositions and methods for the treatment of meibomian gland dysfunction (2023-04-25),

12. 11517586 - Instructions for composition and sensitivity (2022-12-06),

13. 11484516 - Agents for increasing meibomian gland lipid secretion (2022-11-01),

14. 11459351 - Compounds and methods for the treatment of ocular disorders (2022-10-04),

15. 11324775 - Compositions and methods for the treatment of contact lens discomfort (2022-05-10),

Azura Ophthalmics Ltd. is a pharmaceutical company dedicated to delivering innovative solutions to optimize the ocular surface and eyelid health. They focus on developing and commercializing therapeutics for various ophthalmic diseases. With a mission to improve patients' quality of life, Azura Ophthalmics works closely with healthcare professionals to provide effective treatment options.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

21 Patents

#54 in Tel Aviv

#287 in Israel

#29,854 in the World

Tel Aviv, Israel

Azura Ophthalmics Ltd.

Forward Citations = 94

20 inventors:

Omer Rafaeli (20 out of 36 patents)

Yair Alster (13 out of 85 patents)

Shimon Amselem (13 out of 38 patents)

4. Doron Friedman (12 out of 72 patents)

5. Charles Bosworth (8 out of 9 patents)

Please report any incorrect information to [email protected]

Loading…